Potbotics, Inc., a private company, says their mission is to elevate the cannabis industry to higher medical standards by streamlining the prescription, cultivation and consumer cannabis selection process, according to their website (see here: www.Potbotics.com). SNNLive spoke with David Goldstein, Communications Director & Co-Founder of Potbotics, Inc., a private company, at the Marcum MicroCap Conference 2015 in New York City, NY.
Mr. Goldstein begins the interview with an overview of Potbotics, Inc., “Potbotics is a software and technology company that’s really paving the path of going from nutra-ceutical to pharmaceutical. So what that means is that we do very very advanced data mining on the industry, we help quantify the affects of cannabis in order to better recommend it to patients and we also have a recommendation engine so that patients could really take the questions out of the selection process.” He continues with discussing consistency on the flower, potency testing, and education for the patients/consumers.
Mr. Goldstein goes on to explain who the company’s target markets are, state of the Cannabis industry, his thoughts on the time to commercialization of pharmaceutical-grade Cannabis, medical Cannabis programs globally, his background, Canada, and the Company’s business model.
Read the rest of the article: